CAS No. :	1197397-89-9
Formula :	C₂₁H₂₅ClN₂O₂
M.W :	372.89
SMILES Code :	CC(NCCN1C2=C(C3=C1C=CC(C(C)=O)=C3)C=C(C(C)=O)C=C2)C.[H]Cl
Synonyms :	CBL-C137 hydrochloride; Curaxin-137 hydrochloride; Curaxin 137
MDL No. :	MFCD28160457
InChI Key :	IXRKBBVMDMKAEB-UHFFFAOYSA-N
Pubchem ID :	44519123

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

HeLa	0.6 μM	48 hours	Assess cytotoxicity of CBL0137, showing IC50 of 0.1 μM	Cancer Res. 2018 Mar 15;78(6):1431-1443.
Human Fibroblasts (HS68)	5 μM	36 hours	CBL0137 induces ZBP1-dependent cell death in hIFNβ-pretreated HS68 cells.	Nature. 2022 Jun;606(7914):594-602.
Murine Embryonic Fibroblasts (MEFs)	5 μM	24 hours	CBL0137 activates ZBP1-dependent cell death, including necroptosis and apoptosis, by inducing Z-DNA formation.	Nature. 2022 Jun;606(7914):594-602.
NK-92 cells	500 nM	24 hours	CBL0137 treatment upregulated the expression of IFNs and ISGs, and enhanced NK cell-mediated killing of virus-infected cells.	Nucleic Acids Res. 2022 Aug 26;50(15):8700-8718.
HeLa cells	100, 200, 500 nM	24 hours	CBL0137 treatment upregulated the expression of IFNs and ISGs, and inhibited infections of ZIKV, influenza A, and SARS-CoV-2.	Nucleic Acids Res. 2022 Aug 26;50(15):8700-8718.
HEK293T cells	100, 200, 500 nM	24 hours	CBL0137 treatment upregulated the expression of IFNs and ISGs, and inhibited infections of ZIKV, influenza A, and SARS-CoV-2.	Nucleic Acids Res. 2022 Aug 26;50(15):8700-8718.
BJ fibroblasts	1 μM	3 hours	Induced degradation of POLR2A but no degradation of POLR1A was observed.	Nucleic Acids Res. 2024 May 8;52(8):4151-4166.
U2OS cells	1 μM	3 hours	Induced degradation of POLR2A and simultaneously enabled the trapping of Topoisomerases TOP2A and TOP2B on the chromatin.	Nucleic Acids Res. 2024 May 8;52(8):4151-4166.
NDF cells	1 μM	24 hours	To evaluate the toxicity of CBL0137 on normal fibroblasts and p53 activation. Results showed that CBL0137 caused growth arrest at 0.5-1 μM but did not induce senescence markers.	Nucleic Acids Res. 2023 Nov 27;51(21):11836-11855.
HT1080 cells	1 μM	24 hours	To evaluate the toxicity of CBL0137 on HT1080 cells and p53 activation. Results showed that CBL0137 caused growth arrest at 0.5-1 μM but did not induce senescence markers.	Nucleic Acids Res. 2023 Nov 27;51(21):11836-11855.
A1207	0.6 or 2.0 µM	1 or 16 hours	Evaluate the effect of CBL0137 on FACT, p53, and NF-ĸB. Results showed that CBL0137 caused loss of FACT subunits from the soluble protein fraction, significantly increased p53 expression, and inhibited NF-ĸB-dependent transcription.	Neuro Oncol. 2017 Feb 1;19(2):186-196.
U87MG	0.6 or 2.0 µM	1 or 16 hours	Evaluate the effect of CBL0137 on FACT, p53, and NF-ĸB. Results showed that CBL0137 caused loss of FACT subunits from the soluble protein fraction, significantly increased p53 expression, and inhibited NF-ĸB-dependent transcription.	Neuro Oncol. 2017 Feb 1;19(2):186-196.
B16 NF-κB-Luc reporter cells	5 or 10 μM	15 minutes	To assess the effect of CBL0137 on NF-κB pathway activity, results showed that CBL0137 dose-dependently suppressed NF-κB pathway activity.	Cancer Res. 2016 Nov 15;76(22):6620-6630.
B16 melanoma cells	0.7, 1.4, 2.8, or 5.6 μM	15 or 30 minutes	To evaluate the cytotoxic effects of CBL0137 on B16 melanoma cells, results showed that CBL0137 significantly reduced cell viability after 15 and 30 minutes of treatment.	Cancer Res. 2016 Nov 15;76(22):6620-6630.
BE(2)C cells	100 nM	22 hours	Evaluate the effect of CBL0137 on DNA double-strand break repair	Sci Transl Med. 2015 Nov 4;7(312):312ra176.
Non-stem tumor cells (CD133-)	100–600 nM	72 hours	Evaluate the inhibitory effect of CBL0137 on non-stem tumor cells, results showed that CBL0137 effectively inhibited the proliferation of non-stem tumor cells.	Cancer Res. 2016 Apr 15;76(8):2432-42.
GBM stem cells (CD133+)	100–600 nM	72 hours	Evaluate the inhibitory effect of CBL0137 on GBM stem cells, results showed that CBL0137 effectively inhibited the proliferation of GBM stem cells.	Cancer Res. 2016 Apr 15;76(8):2432-42.
HT1080	3 μM	1.5 hours	Study the effect of CBL0137 on FACT chromatin binding via ChIP-seq analysis	Cancer Res. 2018 Mar 15;78(6):1431-1443.
HT1080 cells	3 μM		Investigate the effect of CBL0137 on FACT distribution in transcribed genes, showing that CBL0137 treatment leads to redistribution of FACT from transcribed chromatin regions to other genomic loci.	Sci Adv. 2018 Nov 7;4(11):eaav2131.

Nude mice	U87MG and A1207 orthotopic glioblastoma models	Oral or intravenous	25 mg/kg orally or 70 mg/kg intravenously	Daily oral for 8 days or weekly intravenous twice	Evaluate the antitumor effect of CBL0137 in vivo. Results showed that intravenous administration of CBL0137 significantly increased survival and accumulated more in tumor tissue than in normal brain tissue.	Neuro Oncol. 2017 Feb 1;19(2):186-196.
Mice	TH-MYCN+/+ mice	Intravenous	60 mg/kg	Every 4 days for 8 doses	Evaluate the therapeutic effect of CBL0137 on established neuroblastoma	Sci Transl Med. 2015 Nov 4;7(312):312ra176.
Mice (C57BL/6J)	B16-F10 melanoma model	Intratumoral injection	20 μM (intratumoral injection)	Every two days for a total of 4 doses	CBL0137 significantly enhances the therapeutic effect of anti-PD-1 antibody by inducing ZBP1-dependent necroptosis in fibroblasts of the tumor microenvironment (TME).	Nature. 2022 Jun;606(7914):594-602.
Nude mice	Breast cancer model	Oral gavage	30 mg/kg	Five days a week for six weeks	CBL0137 inhibited the growth of TMD-436 cells-derived tumors but TMD-231 cell-derived tumors were resistant to the treatment	Cancer Res. 2023 Apr 14;83(8):1345-1360
C57BL/6 mice	B16 melanoma model	Isolated limb perfusion (ILP) or intra-arterial infusion (IAI)	0.044, 0.111, 0.222, and 0.444 mg/mL (15-minute perfusion) or 0.022, 0.055, 0.111 and 0.222 mg/mL (30-minute perfusion)	Single 15 or 30-minute perfusion	To evaluate the antitumor efficacy of CBL0137 in vivo against melanoma, results showed that CBL0137 administered via ILP or IAI significantly suppressed tumor growth and was more effective than systemic administration.	Cancer Res. 2016 Nov 15;76(22):6620-6630.
NSG mice	Orthotopic GBM model	Oral administration	0.5 mg/mL	Replaced every 7 days, continuous treatment	Evaluate the therapeutic effect of CBL0137 on orthotopic GBM model, results showed that CBL0137 significantly prolonged the survival of mice.	Cancer Res. 2016 Apr 15;76(8):2432-42.

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.68mL 0.54mL 0.27mL	13.41mL 2.68mL 1.34mL	26.82mL 5.36mL 2.68mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

{[proInfo.proName]}

CAS No.: 1197397-89-9

{[proInfo.proName]}

CAS No.: 1197397-89-9

Alternative Products

Product Details of CBL0137 HCl

Safety of CBL0137 HCl

Related Pathways of CBL0137 HCl

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed